India-based Apollo Hospitals has partnered with French pharma giant Sanofi to improve access to treatment for people with diabetes.
For the first part of the collaboration, Sanofi will extend support to establish 50 Apollo Sugar clinics, both globally and in India.
Apollo Hospitals Group chairman Dr Prathap Reddy said: "Over the years, Apollo Hospitals has benchmarked global best practices in quality healthcare delivery with stringent alignment to approved standards and protocols.
"With the increasing burden of diabetes in our society, we need to act quickly and with a sense of purpose to arrest the disease from claiming more lives."
The Apollo Sugar Clinics will provide access to an integrated diabetes care solution within a clinical infrastructure, and helps in early detection and treatment of diabetes and associated complications.
Sanofi CEO Christopher Viehbacher said: "Sanofi has a heritage of nearly 100 years in developing treatments for diabetes and understands the impact that local expertise and innovative care models can have for patients who are managing their diabetes."
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataApollo Sugar will run as an associate of Apollo Health & Lifestyle, the arm of Apollo providing services in primary and secondary healthcare.
Apollo Sugar chairperson and Apollo Hospitals joint managing director Sangita Reddy said the diabetes patient has access to information, co-morbidities management, counselling, care and treatment at Apollo Sugar Clinics.
Nearly 382 million people are currently suffering from diabetes globally, with India alone accounting for more than 65 million people and 77.2 million individuals diagnosed as being pre-diabetic.
By 2035, the number of people with diabetes in India is expected to rise to 109 million.